{"disease":{"id":"transfusion-dependent-beta-thalassemia","name":"transfusion dependent beta thalassemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06146478","title":"Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Blood Care Clinic","has_results":false},{"nct_id":"NCT07292259","title":"Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Pakistan Blood and Marrow Transplant (PBMT) Group","has_results":false},{"nct_id":"NCT06512298","title":"Plasticizer Exposure and Its Consequences on Health","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT07480980","title":"Evaluation of Micro RNA-155 Expression in Relation to Alloantibody Formation in Transfusion-Dependent Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06664541","title":"Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Georgetown University","has_results":false},{"nct_id":"NCT05991336","title":"Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06606886","title":"Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Bahria University","has_results":false},{"nct_id":"NCT06421636","title":"A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":95,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT07370922","title":"Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT02179359","title":"Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies","phase":"NA","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT07055503","title":"Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"University Research Institute for the Study of Genetic & Malignant Disorders in Childhood","has_results":false},{"nct_id":"NCT03432364","title":"A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Sangamo Therapeutics","has_results":true},{"nct_id":"NCT05762510","title":"A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"First Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT06678165","title":"A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":3,"lead_sponsor_name":"First Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT05860595","title":"Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06219239","title":"Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":3,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}